Chiba, Japan

Mayumi Furukawa

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayumi Furukawa: Innovator in Antimicrobial Solutions

Introduction

Mayumi Furukawa is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of antimicrobial compositions, focusing on safety and effectiveness. Her work is particularly relevant in today's health-conscious environment.

Latest Patents

Furukawa holds a patent for an aqueous antimicrobial composition. This invention addresses the need for a solution that exhibits excellent antibacterial and antifungal activities even at low concentrations. The composition is designed to ensure high safety, low skin irritation, and excellent long-term stability. The formulation includes two or more compounds selected from benzoic acid or a salt thereof, δ-gluconolactone, ketonic acid or a salt thereof, and sorbic acid or a salt thereof, along with at least one dicarboxylic acid represented by General Formula (I) or a salt thereof. This innovative approach enhances the effectiveness of antimicrobial agents while minimizing potential side effects.

Career Highlights

Furukawa is currently associated with Arxada AG, a company known for its commitment to providing innovative solutions in the field of antimicrobial products. Her work at Arxada AG has positioned her as a key player in the development of safe and effective antimicrobial solutions.

Collaborations

Furukawa collaborates with Kazuhiko Sakata, a fellow innovator in the field. Their partnership has fostered a creative environment that encourages the development of groundbreaking solutions in antimicrobial technology.

Conclusion

Mayumi Furukawa's contributions to antimicrobial compositions highlight her dedication to innovation and safety in health-related products. Her patent reflects a significant advancement in the field, showcasing her expertise and commitment to improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…